MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY for MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Proposals to repeal LIFO
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANN RICHARDSON BERKEY | — |
Health Issues HCR
Incentives for health information technology, Affordable Care Act implementation, and other healthcare policy issues. Proposed regulation of medical software. H.R. 3303 "SOFTWARE Act of 2013". S. 2007 "PROTECT Act of 2014".
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANN RICHARDSON BERKEY | — |
Veterans VET
Existing Department of Veterans' Affairs Pharmaceutical Prime Vendor contract.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANN RICHARDSON BERKEY | — |
Medicare/Medicaid MMM
Physician and pharmacy reimbursement issues. Implementation of the Affordable Care Act. H.R. 2869 "Medicare Patient Access to Cancer Treatment Act of 2013" H.R. 1416 " Cancer Patient Protection Act of 2013" H.R. 4302 "Protecting Access to Medicare Act of 2014"Medicare payment and coding for clinical laboratory tests; H.R. 4302: Protecting Access to Medicare Act of 2014, P.L. 113-93. S.806/H.R. 800 To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANN RICHARDSON BERKEY | — |
| MATT BROW | — |
| KEAGAN R LENIHAN | — |
| GEOFF WERTH | — |
Pharmacy PHA
Pharmacy issues, prescription drug supply chain issues, drug shortages, prescription drug abuse and diversion.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANN RICHARDSON BERKEY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.